GlobeNewswireSEP 112 min read$HSCS

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results

Southlake, TX, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- HeartSciences Inc. ( Nasdaq: HSCS. HSCSW ) ( "HeartSciences" or the "Company" ) , an artificial intelligence ( "AI" ) -powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart disease, today announced its ...

Original reporting

GlobeNewswire · HeartSciences Inc.

Published Sep 11, 2025, 8:15 PM UTC

Analysis

alphai AI DeskAI-generated

Added to alphai Sep 11, 2025, 9:00 PM UTC. Informational, not investment advice.

How this was made

alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About alphai AI Desk Scoring methodology Report an issue

HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results — source image — Source · www.globenewswire.com

Decision brief

The 30-second read

$HSCSBullishMed

Why it matters

The earnings report demonstrates progress and potential for growth, which could attract investor interest.

Market read

The news is highly relevant for investors and traders interested in biotech and healthcare innovation sectors.

What to watch

Potential delays in product development or regulatory hurdles could impact future performance.

Timing: Immediate, as the earnings report is recent.

Background

HeartSciences Inc. specializes in AI-powered ECG analysis for early detection of heart disease, aiming to disrupt traditional diagnostic methods.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$HSCSBullishMedium confidence

Context

Primary focus on HeartSciences Inc. financial results and business update.

Expected impact

Moderate upward movement expected in the short term.

Evidence & confidence

The company's positive financial update suggests improved investor sentiment, but the impact is tempered by the overall market conditions and sector performance.

Market effects

Sector

Potential positive impact on the medical technology sector, especially companies focused on AI-powered diagnostics.

Regional

Likely favorable in the U.S. markets, given the company's NASDAQ listing.

Global

Limited, as the news pertains primarily to a U.S.-based company.

Counterpoint

What could challenge this read

The positive earnings report may already be priced in, and sector-wide challenges could limit upside.

Key entities

Company
HeartSciences Inc.
A medical technology firm focused on AI-driven cardiac diagnostics.
Exchange
NASDAQ
The stock exchange where HeartSciences is listed.

Read at source ← All news

AUG 21

$ELOXHighAI 8/10

Top Biotech Gainers: ELOX Clinical Progress, VOGX IPO Success, ARCT Pipeline Updates Drive Gains

Eloxx Pharmaceuticals (ELOX) rose 20% after FDA cleared its Phase 2b trial for exaluren. Vogenx (VOGX) gained 14% post-IPO. Arcturus (ARCT) advanced 21% on pipeline updates. Zhengye (ZYBT) +7% after Nasdaq compliance. Greenwich (GLSI) +10% on extended lock-up. HeartSciences (HSCS) +8% after $1M investment. AC Immune (ACIU) +8% on Phase 1 data.

rttnews.com3 min

JUL 29

$HSCSMed

HeartSciences Inc. (HSCS): Results of Operations and Financial Condition

HeartSciences Inc. (HSCS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea029962701ex99-1.htm PRESS RELEASE, DATED JULY 29, 2026 Exhibit 99.1 HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results ● Company believes proposed

SEC EDGAR 8-K6 min

JUN 25

$HSCSMedAI 8/10

Zcash Miner Fortitude Merging with HeartSciences to Go Public

Fortitude Mining Holdings, a Zcash miner, agreed to merge with HeartSciences Inc. (Nasdaq: HSCS) in an all-stock deal to take the combined company public. The firm is expected to trade on Nasdaq as “TUDE” under the Fortitude brand, with closing expected in 2H 2026. Fortitude reported ~$90M fiscal 2025 gross revenue and ~$20M adjusted EBITDA, and said 48 MW owned power could rise to ~80 MW by end-2026.

finance.yahoo.com3 min

JUN 23

$HSCSMed

Fortitude And HeartSciences Announce Merger To Form Public Zcash Mining Platform; Stock Up

Fortitude Mining Holdings and HeartSciences agreed to merge in an all-stock deal to create a public Zcash mining platform. The combined company is expected to trade under ticker TUDE pending approval, with a target close in H2 2026. Fortitude CEO Andrea Childs will lead the combined team; HeartSciences CEO Andrew Simpson will run the healthcare unit. Fortitude reported annualized 157,000 ZEC production as of May 31, 2026.

rttnews.com4 min

AUG 24

$JNJMedAI 8/10

Is Johnson & Johnson’s $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over?

Johnson & Johnson (JNJ) proposed a $5.5B settlement for 76,000 talc-related lawsuits, but it requires 95% claimant approval and may exceed this amount. The company has $21B in cash and expects to pay $3B in 2027, with further payments starting in 2028. A judge's recent ruling may strengthen JNJ's legal position. Investors weigh the benefit of reduced uncertainty against potential higher costs.

yahoo.com2 min

AUG 23

$CRWDMed

Analysts Back CrowdStrike, Dell and SanDisk Growth

Wall Street analysts maintain positive outlooks on CrowdStrike, Dell, and SanDisk, citing long-term growth in cybersecurity, AI infrastructure, and storage. CrowdStrike's price target raised to $245 by Truist, Dell's to $550 by Evercore, and SanDisk's to $2,250 by J.P. Morgan, all with buy ratings.

ozarab.media2 min